MedPath

Pilot study: A comparison of the extent of haemolysis induced by conventional versus miniaturised extracorporeal circulation during coronary artery bypass grafting surgery, and the influence on the release of damage associated molecular patterns (DAMPs), leukocyte activation and neutrophil extracellular trap (NET) formation.<br>

Completed
Conditions
cell dead of red blood cells
haemolysis
10018911
10011082
10007593
Registration Number
NL-OMON45709
Lead Sponsor
Amphia Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Elective CABG operation with extracorporeal circulation

Exclusion Criteria

o Kidney insufficiency: creatinine >150 µmol/L
o Liver insufficiency: ASAT >80 U/L
o Left ventricular function (LVF): <30% Ejection fraction (EF)
o Body surface area (BSA): <1.6; *2.1 m²
o Carotid artery stenosis
o Pre-operative Haemoglobin: <7,5; *10 mmol/L
o Pre-operative red blood cell transfusion: <14 days before CABG procedure
o Splenectomy (influences the IgM levels used to determine the amount of haemodilution)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is the amount of haemolysis as examined by determining<br /><br>cell free haem/cell free haemoglobin, haemoglobin, haematocrit and lactate<br /><br>dehydrogenase. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are markers for the release of DAMPs (nucleosomes,<br /><br>cell free DNA HMGB1), the activation of leukocytes (calprotectin) and<br /><br>neutrophils (human neutrophil elastase-alpha1 antitrypsin complexes) and the<br /><br>formation of neutrophil extracellular traps (myeloperoxidase(MPO)-nucleosome<br /><br>complexes). </p><br>
© Copyright 2025. All Rights Reserved by MedPath